Convergence Investment Partners, LLC Vanda Pharmaceuticals Inc. Transaction History

Convergence Investment Partners, LLC

  • $431 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 23, 2019
SELL
$13.37 - $18.85 $160,065 - $225,672
-11,972 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$17.59 - $31.05 $210,587 - $371,730
11,972 New
11,972 $220,000
Q4 2018

Feb 13, 2019
SELL
$18.97 - $31.47 $236,916 - $393,028
-12,489 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$18.25 - $23.0 $227,924 - $287,247
12,489 New
12,489 $287,000

Others Institutions Holding VNDA

# of Institutions
154
Shares Held
43.8M
Call Options Held
33.8K
Put Options Held
28.7K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $250M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email